01548nam 2200373 450 991068860080332120230623194921.010.5772/intechopen.87599(CKB)5400000000042198(NjHacI)995400000000042198(EXLCZ)99540000000004219820230623d2021 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierMultiple Myeloma /edited by Ota FuchsLondon, England :IntechOpen,2021.1 online resource (126 pages)1-83968-622-7 This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow-microenvironment interactions.BonesCancerBonesTumorsBonesCancer.BonesTumors.616.99471Fuchs OtaNjHacINjHaclBOOK9910688600803321Multiple Myeloma1522185UNINA